FIGO's updated recommendations for misoprostol used alone in gynecology and obstetrics
- September 1st, 2017
- Medical Abortion
- Morris, J.L., Winikoff, B., Dabash, R., Weeks, A., Faudes, A., Gemzell-Danielsson, K., Kapp, N., Castleman, L., Kim, C., Ho, P.C., Visser, G.H.A.
Int J Gynaecol Obstet; 2017 Sep; 138(3):363-366; doi:10.1002/ijgo.12181
Background: In 2012, the International Federation of Obstetrics and Gynecology (FIGO) produced a chart detailing recommended dosages of misoprostol when used alone, for a variety of gynecologic and obstetric indications. In light of new evidence1-13 and through expert deliberation, this chart has now been revised and expanded (Fig. 1). Some areas were particularly challenging to develop given the limited, low‐quality, or inconsistent evidence. The present commentary is intended to explain some of the changes and decisions made.